SCHEMBL31258705

SCHEMBL31258705

O=C(NNC(=O)C(F)F)c1ncc2c(Cl)cc(SCc3ccccc3)cn12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
RXFP1 Q9HBX9 1/20 0.33
MAPK1 P28482 1/20 0.33
GRM4 Q14833 1/20 0.32
HDAC8 Q9BY41 2/20 0.32
CXCR2 P25025 1/20 0.32
ABL1 P00519 1/20 0.32
SRC P12931 1/20 0.32
KDM6B O15054 1/20 0.31
KDM4A O75164 1/20 0.31
KDM4D Q6B0I6 1/20 0.31
HIF1AN Q9NWT6 1/20 0.31
KDM5B Q9UGL1 1/20 0.31
KDM2A Q9Y2K7 1/20 0.31
EGLN1 Q9GZT9 1/20 0.31
MCL1 Q07820 1/20 0.31
BCL2A1 Q16548 1/20 0.31
KDM4E B2RXH2 1/20 0.31
HDAC3 O15379 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31049390 0.90 CXCR2 (0.34) MEN1KMT2AMAPK1GRM4HDAC8
SCHEMBL31258801 0.85 ALDH1A1 (0.38) MEN1KMT2ARXFP1GRM4HDAC8
SCHEMBL31258770 0.84 KDM4E (0.37) MEN1KMT2ARXFP1MAPK1ABL1
SCHEMBL31258709 0.84 HDAC8 (0.38) MEN1KMT2ARXFP1MAPK1GRM4
SCHEMBL30713264 0.81 CA12 (0.40) MEN1KMT2AMAPK1GRM4ABL1
SCHEMBL30713202 0.80 KMT2A (0.43) MEN1KMT2ARXFP1MAPK1NPC1
SCHEMBL27389846 0.80 ALDH1A1 (0.32) SCN9ANPC1POLBRAB9AALDH1A1
SCHEMBL31049368 0.78 CXCR2 (0.35) MEN1KMT2AMAPK1HDAC8CXCR2
SCHEMBL31258706 0.77 KMT2A (0.35) MEN1KMT2AGRM4HDAC8CXCR2
SCHEMBL31258713 0.77 SMN1; SMN2 (0.44) MEN1KMT2ANPC1POLBRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4716532-A2 BICYCLIC HETEROARYL COMPOUNDS Quantx Biosciences US, Inc. (US) 2026-04-01 EP disclosed
EP-4549438-A1 FIVE-MEMBERED AND SIX-MEMBERED NITROGEN-CONTAINING COMPOUND, AND INTERMEDIATE, PREPARATION METHOD AND USE THEREOF Hangzhou Synrx Therapeutics Biomedical Technology Co., Ltd. (CN) 2025-05-07 EP disclosed
WO-2024243304-A2 BICYCLIC HETEROARYL COMPOUNDS QUANTX BIOSCIENCES US, INC. (US) 2024-11-28 WO disclosed